Effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal tumor
Wei-Ping Ma, Jinli Li
Abstract
Wei-Ping Ma, Jinli Li
Abstract
Objective To observe the effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal cancer. Methods From January 2014 to January 2017, 100 patients with gastrointestinal cancer in Yuncheng Central Hospital were selected in the research and randomly divided into two groups according to the digital table, with 50 cases in each group.All the patients underwent chemotherapy, the observation group was given enteral nutritional emulsion during chemotherapy.The indicators of nutritional status, immune function, the effect of chemotherapy, the incidence of adverse reactions were compared between the two groups. Results After treatment, the prealbumin, albumin, transferrin and hemoglobin levels in the observation group were (0.30±0.07)g/L, (32.93±1.67)g/L, (2.61±0.15)g/L, (109.94±2.31)g/L, respectively, which in the control group were (0.19±0.09)g/L, (30.89±1.49)g/L, (2.49±0.14)g/L, (108.07±2.04)g/L, respectively, there were statistically significant differences between the two groups(t=6.822, 6.445, 4.135, 4.291, all P<0.05). After treatment, the CD3+ , CD4/CD8, NK cells in the observation group were (43.84±7.65)%, (1.70±0.18) and (37.78±7.51)%, respectively, which in the control group were (36.12±6.57)%, (1.52±0.19) and (31.07±4.20)%, respectively, there were statistically significant differences between the two groups(t=5.413, 4.863, 6.124, all P<0.05). The objective response rate of the observation group (64%) was significantly higher than that of the control group(44%)(χ2=4.026, P<0.05). The incidence rate of adverse reaction of the observation group (18%) was significantly lower than that of the control group(36%)(χ2=4.110, P<0.05). Conclusion Enteral nutritional emulsion can effectively improve the nutritional status and immune function of patients with gastrointestinal cancer during chemotherapy, but also can effectively enhance sensitivity to chemotherapy, improve the effect of chemotherapy, and the safety is reliable. Key words: Gastrointestinal neoplasms; Gastrointestinal neoplasms; Fat emulsions, intravenous; Parenteral nutrition; Immune function; Nutritional status
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal cancer. Methods From January 2014 to January 2017, 100 patients with gastrointestinal cancer in Yuncheng Central Hospital were selected in the research and randomly divided into two groups according to the digital table, with 50 cases in each group.All the patients underwent chemotherapy, the observation group was given enteral nutritional emulsion during chemotherapy.The indicators of nutritional status, immune function, the effect of chemotherapy, the incidence of adverse reactions were compared between the two groups. Results After treatment, the prealbumin, albumin, transferrin and hemoglobin levels in the observation group were (0.30±0.07)g/L, (32.93±1.67)g/L, (2.61±0.15)g/L, (109.94±2.31)g/L, respectively, which in the control group were (0.19±0.09)g/L, (30.89±1.49)g/L, (2.49±0.14)g/L, (108.07±2.04)g/L, respectively, there were statistically significant differences between the two groups(t=6.822, 6.445, 4.135, 4.291, all P<0.05). After treatment, the CD3+ , CD4/CD8, NK cells in the observation group were (43.84±7.65)%, (1.70±0.18) and (37.78±7.51)%, respectively, which in the control group were (36.12±6.57)%, (1.52±0.19) and (31.07±4.20)%, respectively, there were statistically significant differences between the two groups(t=5.413, 4.863, 6.124, all P<0.05). The objective response rate of the observation group (64%) was significantly higher than that of the control group(44%)(χ2=4.026, P<0.05). The incidence rate of adverse reaction of the observation group (18%) was significantly lower than that of the control group(36%)(χ2=4.110, P<0.05). Conclusion Enteral nutritional emulsion can effectively improve the nutritional status and immune function of patients with gastrointestinal cancer during chemotherapy, but also can effectively enhance sensitivity to chemotherapy, improve the effect of chemotherapy, and the safety is reliable. Key words: Gastrointestinal neoplasms; Gastrointestinal neoplasms; Fat emulsions, intravenous; Parenteral nutrition; Immune function; Nutritional status
Key concepts: Medicine, Gastroenterology, Internal medicine, Enteral administration, Chemotherapy, Incidence (geometry), Parenteral nutrition, Gastrointestinal cancer